Table 1.
Summary of UV-Vis absorption shifts and intensity changes for AuNP-Based Formulations.
| Sample | Wavelength (nm) | Intensity | Description | Shifts/Change |
|---|---|---|---|---|
| AuNPs (Fig. 4A-Yellow) | 559 | 0.61 | Plasmon absorption band of colloidal gold nanoparticles with a size of 90 nm, stabilized by AsP. | No shift/change |
| 236 | 1.07 | Corresponding to AsP group. | No shift/change | |
| GEM (Fig. 4A-Dark blue) | 270 | 0.71 | Two distinct absorption bands; GEM sample used in the reaction. | No shift/change |
| 238 | 0.54 | |||
| Au-GEM (Fig. 4A-Green) | 562 | 0.36 | Plasmon band of gold nanoparticles after GEM binding. | Shifted from 559 nm (intensity decrease from 0.61 to 0.30). |
| 270 | 0.33 | GEM drug bond on the nanoparticle surface. | No shift/change | |
| 235 | 0.15 | Overlapping bands of AsP (during synthesis) and GEM. | No shift/change | |
| Au-GEM-AsP-Phys (Fig. 4A-Purple) | 571 | 0.42 | Plasmon band of gold nanoparticles in the physical formulation. | Shifted from 559 nm to 571 nm (intensity decreased from 0.61 to 0.42). |
| 240–280 | High | Overlapping bands of AsP and GEM. | No shift/change | |
| Au-GEM-AsP-MOD (Fig. 4A-Light blue) | 568 | 0.27 | Plasmon band of gold nanoparticles in the surface-modified formulation. | Shifted from 559 nm to 568 nm (intensity decreased from 0.61 to 0.27), consistent with surface modification and altered electronic environment. |
| 240–280 | High | Overlapping bands of AsP and GEM. | No shift/change |